ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$18.60
0.12 (0.65%)
▲
5d:
+4.91%
30d:
-2.62%
90d:
+5.62%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ZLAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ZLAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $18.60, which is considered slightly high relative to its 30-day fair value range of $17.04 to $18.87.
Technical Outlook: Technically, ZLAB is showing sideways momentum. The price is approaching resistance at $19.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.30 (+80.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZLAB is showing sideways momentum. The price is approaching resistance at $19.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.30 (+80.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$17.04 -
$18.87
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 80.2% below Wall St target ($33.30)
Trading Range Analysis
30-Day Trading Range
$17.04 -
$18.87
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$16.26
Resistance Level
$19.11
Current Trend
Sideways
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.58
Wall Street Target
$33.30
(+80.2%)
Revenue Growth (YoY)
-6.5%
Profit Margin
-39.3%
Share & Embed Analysis
Last updated: June 23, 2026 11:32 AM ET
Data refreshes hourly during market hours. Next update: 12:32 PM
Data refreshes hourly during market hours. Next update: 12:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2739 shares
2026-04-06
Yajing Chen
SELL
853 shares
2026-04-06
Ying Du
SELL
2653 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 56 HOLD |
